© 2018  by Rare Diseases South Africa

Terms and Conditions Apply


  • Grey Facebook Icon
  • Grey Twitter Icon

Meet the Judging Panel

Lauren Pretorius 

For the past 20 years Lauren has worked in the field of Corporate Social Investment, developing strategies and consulting to both companies and non-profit organisations in this specialized field.


Lauren’s introduction to cancer civil society came in 2003 when one of her companies was approached to help develop a breast cancer advocacy organisation.   In 2005, Lauren consolidated her ventures to formed Prime Consulting on the belief that it is imperative that the social responsibility sector is run professionally and transparently in order to deriving maximum benefit for its

investors, and with the vision for a firm of consultants providing  bespoke services required to ensure this.

In the corporate sector, Lauren has developed and implemented CSI strategies for various organisations, including; Airports Company South Africa (ACSA), Mpumalanga Office of the Premier  - development of Brand Mpumalanga and M-NET.

In 2009, she was appointed as a Regional Consultant to the American Cancer Society.

Lauren has been instrumental in the strategic development of a number of cancer NGOs and support groups. She currently sits as CEO of Campaigning for Cancer and is a director of the World Lymphoma Coalition.

Dr Konji Sebati 

Dr. Konji Sebati is the Chief Executive Officer of IPASA, the Innovative Pharmaceutical Association of South Africa; an Association of 26 of the largest multi-national, research-based pharmaceutical companies.
A Medical Practitioner by training with post-graduate diplomas in Health Planning Management and Hospital Administration, Paediatrics and Child Health; Konji is a resourceful, hardworking, and strategic person, a great communicator and networker, with excellent management and leadership skills.

She gained extensive experience and networks throughout Africa and Internationally due to her career in government, the pharmaceutical industry, her diplomatic tenure and working for the United Nations on Intellectual Property.
She has over 25 years’ experience in the private and public sector; both in South Africa and within Africa, especially Kenya where she obtained her Medical degree, and Ghana; and extensive networks in Tanzania, Malawi, Zambia, Nigeria and Cote d’Ivoire.
Konji has also worked for several years in Corporate Affairs and with a Foundation when she was with Pfizer Pharmaceuticals, responsible for setting up medicine donation programs which included training, in developing countries.
Her most recent experience as an International civil servant with the United Nations Agency, WIPO, the World Intellectual Property Organisation, was heading the Department of Global Challenges; a division that sought to find ways to use Intellectual Property for development in health, green technologies and agriculture; working with patent holders to voluntarily share or donate their Intellectual Property Rights to Developing countries for Research and Development of new medicines and technologies in these fields.
Her work at WIPO also involved working with 187 Member States to agree on an International legal instrument to protect and promote Traditional Knowledge, Traditional Cultural Expressions and Genetic Resources.
Konji sits on the Board member of Medicines for Malaria Venture (MMV), a non-profit Research and Development Public-Private Partnership for new Malaria medicines.

Yolanda Moyo

Yolanda currently leads a South Africa Research and Development (R&D) advocacy team at PATH. She has worked in public health research and in advocacy and public policy, she currently chairs two civil society advocacy coalitions in South Africa. The South African Health Technologies Advocacy Coalition (SAHTAC) and the South African Civil Society for Women's Adolescents' and Children's Health (SACSOWACH). Yolanda is a champion for civil society engagement in public policy making processes.

She has spent many years advocating for transparent and inclusive policy processes, particularly for policies that impact on the health of women and children. Yolanda has been a member of the South African National AIDS Council (SANAC) women’s sector since 2012, and has been tracking the implementation of the National Strategic Plan for HIV, TB and STI’s (NSP), through the SAHTAC coalition. She is currently working on developing accountability tracking tools for civil society to track policy development and implementation to enable them to hold their leaders accountable to promises that they have made in specific health policies. Yolanda is experienced in qualitative research, she has conducted a number of research studies in public health that involved the collection and analysis of qualitative and quantitative data. She has been a local Principal Investigator of a USAID funded evaluation of a 5 year project. Yolanda has been part of global PATH teams that have conducted user-acceptability studies of various health technologies in South Africa including being in the protocol development team for a study to evaluate a paper applicator for microbicide delivery in collaboration with CAPRISA. The Rilpivirine micro-array patch user acceptability study of the prototype micro-array patches, and feasibility study of the use HIV-Self testing diagnostic kits by lay users in South Africa, all these studies used qualitative methodology. She has experience in preparing submissions of protocols to local ethics committees, namely Wits and HSRC ethics committees, research determination committees (RDC). Recently Yolanda was a member of the expert technical working group that drafted the African Union (AU) Health Research and Innovation strategy in partnership with the NEPAD Agency. She is a qualified nurse with a Masters Degree in Clinical Drug Development from Queen Mary University of London, UK, a Diploma in Chemistry from the Open University, UK, and a certificate in Clinical Pharmacology from the Thames Valley University, UK. Yolanda has been accepted at the London School of Hygiene and Tropical Medicine (LSHTM) where she will begin a Doctor of Public Health degree program on a part-time basis in September 2018.

Katharine Child

Katharine Child is a journalist at the Sunday Times

She loves her job a lot even though the sub editors, who fix her grammer, can’t believe she used to teach English in Asia.

She used to consider Cape Town her home but  Johannesburg but is now part of who she is

She is glad she moved to this big, friendly city to find her career and give a voice to the voiceless.  

She is scatter brained and lives in her own world, but somehow gets stuff done.


She loves children and is looking for some to become an honourary auntie and babysitter too.

Coffee and wine keep her going and chocolate and Chinese food also help.   Her favourite thing to do is see family in Cape Town or go travelling to unusual countries.

She also loves twitter!

She hardly knows of a single celebrity or sports hero and still listens to uncool music like Celine Dion and music from the eighties.

Raffaella Ruttell

Raffaella Ruttell qualified as a pharmacist in Durban in 19-something. After 6 years in retail pharmacy, as a newly married woman, she moved to the City of Gold where she decided to try her hand at hospital pharmacy. For the next 14 years she travelled the country overseeing the operational efficiency of pharmacies within certain hospitals. At the start of the millennium she joined the corporate world heading up the Chronic Illness division at a major health insurance company.


Eighteen years later she is still a corporate nine-to –fiver and currently heads up a division focused on providing support to patients and their families who are going through particularly difficult situations. In this current role she is grateful that she has the privilege to work and engage with people from all walks of life, all of whom are inspirational in the courageous way they embrace life despite the enormous challenges they face every day.  In her spare time, she rescues puppies